Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Tables)

v3.24.1.1.u2
Common Stock (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Summary of Stock Option Activity

A summary of stock option activity is presented below:

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding as of January 1, 2024

 

 

8,141,035

 

 

$

8.28

 

 

 

7.6

 

 

$

117,384

 

Granted

 

 

1,858,200

 

 

 

23.80

 

 

 

 

 

 

 

Exercised

 

 

(167,813

)

 

 

6.61

 

 

 

 

 

 

2,615

 

Outstanding as of March 31, 2024

 

 

9,831,422

 

 

$

11.24

 

 

 

7.8

 

 

$

69,765

 

Options Exercisable at March 31, 2024

 

 

4,457,253

 

 

$

7.63

 

 

 

6.5

 

 

$

42,026

 

Schedule of Assumptions Used to Estimate Fair Value of Stock Options

The fair value of each award is estimated using Black-Scholes based on the following assumptions:

 

 

 

Three months ended March 31,

 

 

2024

 

2023

Risk-free interest rate

 

3.78%—4.28%

 

3.38%—3.95%

Expected term

 

6.1 years

 

6.1 years

Expected volatility

 

106%

 

106%

Expected dividend yield

 

0%

 

0%

Summary of Stock-Based Compensation

The Company has recorded stock-based compensation in the accompanying statements of operations as follows:

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

1,960

 

 

$

1,236

 

General and administrative

 

 

1,831

 

 

 

1,244

 

Total

 

$

3,791

 

 

$

2,480